Package 55315-435-53

{"route": ["ORAL"], "spl_id": "8dd0ce14-1eb8-4c4a-9f4a-2671fabfa7c0", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0358602828196"], "unii": ["5QZO15J2Z8"], "rxcui": ["310273"], "spl_set_id": ["81b105a1-01fe-51d7-e053-2991aa0a71bc"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Fred's, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (55315-435-53)  / 25 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "55315-435-53", "marketing_start_date": "20160426"}], "brand_name": "Famotidine", "product_id": "55315-435_8dd0ce14-1eb8-4c4a-9f4a-2671fabfa7c0", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "55315-435", "generic_name": "Famotidine", "labeler_name": "Fred's, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "20 mg/1"}], "application_number": "ANDA206531", "marketing_category": "ANDA", "marketing_start_date": "20160426", "listing_expiration_date": "20261231"}